During the past decade, Siteman Cancer Center - South County conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 44 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 32 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siteman Cancer Center - South County" #1 sponsor was "National Cancer Institute (NCI)" with 102 trials, followed by "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "Pfizer" with 22 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center - South County" #1 collaborator was "National Cancer Institute (NCI)" with 82 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center - South County" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (9 trials), "Metastatic Malignant Solid Neoplasm" (7 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials) and "Stage IVB Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Siteman Cancer Center - South County" in a lesser frequency.

Most popular intervention types in "Siteman Cancer Center - South County" are "Drug" (167 trials), "Other" (92 trials), "Biological" (83 trials), "Procedure" (70 trials) and "Radiation" (56 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (41 trials), "Computed Tomography" (39 trials), "Biospecimen Collection" (37 trials), "Laboratory Biomarker Analysis" (36 trials) and "Nivolumab" (31 trials). Other intervention names were less common.

The vast majority of trials in "Siteman Cancer Center - South County" are 185 trials for "All" genders, 18 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Siteman Cancer Center - South County". undefined are not yet recruiting, 83 are recruiting, 93 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Siteman Cancer Center - South County, 12 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Siteman Cancer Center - South County, 30 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".